SCHEMBL17433366

SCHEMBL17433366

O=C(Nc1nc2ccccc2s1)c1cc(Br)ccc1O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.64
CNR1 P21554 1/20 0.58
DHODH Q02127 1/20 0.58
NPC1 O15118 6/20 0.58
RAB9A P51151 5/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
ALDH1A1 P00352 2/20 0.57
ADORA1 P30542 2/20 0.56
TMIGD3 P0DMS9 1/20 0.56
STAT1 P42224 1/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
PKM P14618 1/20 0.56
PAX8 Q06710 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
KDM4E B2RXH2 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17433477 0.90 RAB9A (0.65) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL17179224 0.90 DYRK1A (0.65) TOP1NPC1RAB9ASMN1; SMN2ADORA1
SCHEMBL2245502 0.86 DHODH (0.67) CNR1DHODHNPC1RAB9AMEN1
SCHEMBL17770342 0.85 DHODH (0.76) TOP1CNR1DHODHNPC1RAB9A
SCHEMBL19194695 0.85 SCD (0.66) TOP1CNR1DHODHNPC1RAB9A
SCHEMBL17178426 0.85 RAB9A (0.69) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL23607124 0.84 CNR1 (0.71) TOP1CNR1DHODHNPC1RAB9A
SCHEMBL30576822 0.84 DHODH (0.60) TOP1CNR1DHODHNPC1RAB9A
SCHEMBL30576813 0.84 DHODH (0.78) TOP1CNR1DHODHNPC1RAB9A
SCHEMBL30576765 0.84 DHODH (0.60) TOP1CNR1DHODHNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170216252-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS SIMON FRASER UNIVERSITY (CA) 2017-08-03 US disclosed
US-20170216252-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS SIMON FRASER UNIVERSITY (CA) 2017-08-03 US disclosed
WO-2016004513-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS SIMON FRASER UNIVERSITY (CA) 2016-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170216252-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS PDK1, PDK3, PDK2 TOP1 2032/4885CNR1 4420/4885DHODH 2170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.